Pictet North America Advisors SA Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Pictet North America Advisors SA increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,517 shares of the healthcare conglomerate’s stock after buying an additional 132 shares during the quarter. Pictet North America Advisors SA’s holdings in UnitedHealth Group were worth $9,873,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at about $37,000. Friedenthal Financial acquired a new position in shares of UnitedHealth Group in the third quarter valued at about $51,000. DecisionPoint Financial LLC boosted its stake in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the last quarter. Finally, Highline Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group in the third quarter worth about $55,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.7 %

UNH opened at $531.31 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The business has a fifty day simple moving average of $524.58 and a 200-day simple moving average of $563.71. The firm has a market cap of $488.96 billion, a P/E ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the business posted $5.83 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent research reports. Wells Fargo & Company lowered their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Barclays lowered their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Finally, Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.